Newbridge Financial Services Group, Inc. Crispr Therapeutics Ag Transaction History
Newbridge Financial Services Group, Inc.
- $275 Million
- Q3 2024
A detailed history of Newbridge Financial Services Group, Inc. transactions in Crispr Therapeutics Ag stock. As of the latest transaction made, Newbridge Financial Services Group, Inc. holds 200 shares of CRSP stock, worth $8,384. This represents 0.0% of its overall portfolio holdings.
Number of Shares
200
Previous 776
74.23%
Holding current value
$8,384
Previous $41,000
78.05%
% of portfolio
0.0%
Previous 0.02%
Shares
12 transactions
Others Institutions Holding CRSP
# of Institutions
490Shares Held
58MCall Options Held
1.1MPut Options Held
1.9M-
Capital International Investors Los Angeles, CA7.93MShares$332 Million0.07% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl7.5MShares$314 Million3.35% of portfolio
-
State Street Corp Boston, MA2.99MShares$125 Million0.01% of portfolio
-
Sumitomo Mitsui Trust Holdings, Inc.2.97MShares$124 Million0.1% of portfolio
-
Nikko Asset Management Americas, Inc.2.97MShares$124 Million1.61% of portfolio
About CRISPR Therapeutics AG
- Ticker CRSP
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 78,009,296
- Market Cap $3.27B
- Description
- CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious diseases using its proprietary Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. Its CRISPR/Cas9 is a gene editing technology that allows for precise directed changes to genomic DNA....